$ORCL

Procure-to-pay market projected to nearly double from $8.21B to $15.15B by 2033, driven by AI and cloud-based automation adoption across enterprises.

Oracle faces a class action lawsuit alleging it failed to disclose financial risks tied to its AI infrastructure investments, citing misaligned capital spending and revenue growth.

Healthcare workforce management systems market expected to triple to $6.26B by 2035, driven by hospitals adopting digital solutions to address staffing challenges and labor pressures.

Two energy infrastructure companies offer attractive 6-7% dividend yields, benefiting from data center demand surge and stable fee-based revenue models.

Ardent Health investors must join securities class action by March 9, 2026, alleging company misrepresented financial reporting and insurance coverage practices.

Oracle faces a securities class action lawsuit over allegedly misleading AI strategy disclosures. Investors must act by April 6, 2026, regarding stock purchased between June-December 2025.

Growth ETFs offer buying opportunities as tech faces 2026 headwinds. VUG and MGK provide diversified exposure, while IGV's tech decline may attract contrarian investors.

Oracle's cloud division grows 66% yearly with $523B AI backlog, but aggressive expansion increases debt and customer concentration risk with OpenAI.

Oracle stock dropped 5% after Nvidia cut its OpenAI investment commitment from $100B to $30B, raising concerns about OpenAI's funding and Oracle's $300B infrastructure deal viability.

Cardiology EHR market projected to grow from $3.52B in 2026 to $5.44B by 2035, driven by digitization and regulatory requirements.

Class action lawsuits filed against Paysafe and Oracle for material omissions in financial disclosures. Paysafe failed to disclose high-risk clients; Oracle misrepresented AI infrastructure costs.

Oracle faces a securities class action lawsuit alleging it misrepresented AI infrastructure strategy disclosures, failing to reveal substantial capital expenditures and associated risks to investors between June-December 2025.

AMD strengthens AI chip market position through partnerships with OpenAI, Oracle, and TCS. Analysts project continued enterprise adoption and revenue growth in 2026.

Salesforce outpaces Oracle on valuation and AI momentum, trading at lower P/E while its Agentforce AI division surges 330% YoY. Oracle faces headwinds from heavy capex and execution risks.

Micron and Oracle positioned to outpace ASML's valuation due to memory supply constraints and enterprise software growth from AI investments, despite current market headwinds.

Clinical trial software market projected to nearly triple to $34.15B by 2035, driven by pharmaceutical industry's digital transformation and increased adoption of AI-enabled solutions.

Oracle stock dropped 50% from peak due to $300B OpenAI deal execution risks. Heavy upfront investment required before 2027 revenue generation creates execution challenges and concentration risk.

Oracle faces securities lawsuit for allegedly misrepresenting AI infrastructure investment returns and failing to disclose significant financial obligations and project delays.

Portnoy Law Firm files class action against Oracle for failing to timely disclose a $15 billion CapEx increase tied to its OpenAI partnership deal.

Tech giants spend $400B on AI infrastructure, creating winners with strong balance sheets and losers burdened by debt in this capital-intensive race.